News
Increasing patient adherence to treatment is a public health goal
22/04/2010
---
Medicines top counterfeit concern list in Europe - consumers call for tougher safety measures
19/11/2009
---
Study validates benefits of drug authentication
24/09/2009
---
Aegate launches traceability service, extending drug authentication to the distribution chain
17/08/2009
---
Traceability introduces another barrier against counterfeit medicines
Aegate Reaches Two Million Authentication Landmark
30/06/2009
---
Major European Generic Pharmaceutical Companies join Aegate patient safety communications service
16/03/2009
---
Leading generic pharmaceutical companies in Belgium are utilizing Aegate's unique drug authentication and patient safety communications service, with the announcement today that Teva joins the growing list of other major European generics companies such as Mylan and ratiopharm, to experience the benefits that the real-time service provides.
IT Critical to Running an Efficient, Safe and Effective Pharmacy, Survey Finds
26/01/2009
---
Pharmacists in Belgium recognise the benefits real-time communication brings in providing a more efficient pharmacy to patients
Aegate increases availability of patient safety service to 80% of Belgium pharmacies
16/10/2008
---
Aegate announces partnership with Officinall
World’s First Independent Study Proves Authenticating Drugs at the Point of Dispensing Protects Consumers
18/09/2008
---
Aegate’s drug authentication service is 100 per cent reliable and effective, corroborates report
Report into online counterfeit drug trade highlights why local
01/07/2008
---
95.6% of online pharmacies operate illegally; nearly two thirds of online drugs found to be fake; problem moves beyond lifestyle drugs to cancer and serious cardiovascular diseases
Counterfeit Drugs: Decisive And Global Action Is Needed- Pharmaceuticalonline.com
05/05/2008
---
Twenty-three pharmaceutical companies join forces with Aegate in fight for patient safety
29/04/2008
---
At the launch today of a white paper on the use of mass serialisation for patient safety, developed in collaboration with leading industry analysts Frost and Sullivan, Aegate’s commitment to patient safety across Europe has been bolstered by the announcement that 23 leading pharmaceutical companies are now working alongside the company in its fight to assure the quality and safety of medicines that are dispensed to patients across Europe.
Aegate goes live in Greece
16/10/2007
---
Unique patient safety initiative launched for Greek pharmacists
Aegate appoints Chief Operations Officer, Brian Thornley, GSK and EFPIA supply chain expert, to growing Aegate team
02/07/2007
---
Former Director of European Supply Chain for GlaxoSmithKline, Brian Thornley, has joined Aegate, the growing UK-based pharmaceutical authentication company active in the fight against counterfeit and substandard medicines, as Chief Operations Officer, effective immediately.
Next stop: Greece
18/05/2007
---
Aegate announces it is entering the Greek market, offering a simple and effective solution to protect pharmaceutical brands against the risks of substandard or illegal medicines reaching patients

